On Monday, March 27, 2023, at 10:00 a.m. EDT, the Supreme Court of the United States will hear oral arguments in Amgen Inc. v. Sanofi, No. 21-757. William H. Milliken, a director in Sterne Kessler’s Trial & Appellate Practice Group and co-chair of the firm's appellate practice, will be live tweeting updates from the firm’s account, @sternekessler. The Twitter coverage will begin at 9:30 a.m. EDT and continue throughout the proceedings.
By way of background, the Supreme Court granted certiorari in Amgen Inc. v. Sanofi in November 2022 to review the enablement requirement of patent law. Read more about the case in the article "Supreme Court Poised To Alter Patentability of Pharmaceutical, Life-Science Innovations," authored by Directors William H. Milliken, Deirdre M. Wells, and Kristina Caggiano Kelly.
Sterne Kessler will continue to provide updates and analysis on this closely watched case up to the Court’s decision and beyond.